Your browser doesn't support javascript.
loading
Summary of the clinical practice manual for late-onset hypogonadism.
Ide, Hisamitsu; Akehi, Yuko; Fukuhara, Shinichiro; Ohira, Shin; Ogawa, Sumito; Kataoka, Tomoya; Kumagai, Hiroshi; Kobayashi, Ko; Komiya, Akira; Shigehara, Kazuyoshi; Syuto, Takahiro; Soh, Jintetu; Tanabe, Makito; Taniguchi, Hisanori; Chiba, Koji; Matsushita, Kazuhito; Mitsui, Yozo; Yoneyama, Takahiro; Shirakawa, Tomoya; Fujii, Yasuhisa; Kumano, Hiroaki; Ueshiba, Hajime; Amano, Toshiyasu; Sasaki, Haruaki; Maeda, Seiji; Mizokami, Atsushi; Suzuki, Kazuhiro; Horie, Shigeo.
Afiliación
  • Ide H; Department of Urology, Dokkyo Medical University, Saitama Medical Center, Saitama, Japan.
  • Akehi Y; Diabetes Therapeutics and Research Center, Institute of Advanced Medical Sciences, Tokushima University, Tokushima, Japan.
  • Fukuhara S; Department of Urology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Ohira S; Department of Urology, Kawasaki Medical School, Okayama, Japan.
  • Ogawa S; Department of Geriatric Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Kataoka T; Department of Clinical Pharmaceutics, Graduate School of Medical Sciences, Nagoya City University, Nagoya, Aichi, Japan.
  • Kumagai H; The Leonard Davis School of Gerontology, University of Southern California, Los Angeles, California, USA.
  • Kobayashi K; Department of Urology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Komiya A; Department of Urology, Kameda Medical Center, Chiba, Japan.
  • Shigehara K; Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Ishikawa, Japan.
  • Syuto T; Department of Urology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan.
  • Soh J; Department of Urology, Japanese Red Cross Society Kyoto Daini, Kyoto, Japan.
  • Tanabe M; Department of Endocrinology and Diabetes Mellitus, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
  • Taniguchi H; Department of Urology and Andrology, Kansai Medical University, Hirakata, Osaka, Japan.
  • Chiba K; Department of Urology, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan.
  • Matsushita K; Department of Urology, Juntendo University, Graduate School of Medicine, Tokyo, Japan.
  • Mitsui Y; Department of Urology, Toho University School of Medicine, Tokyo, Japan.
  • Yoneyama T; Department of Advanced Transplant and Regenerative Medicine, Hirosaki University Graduate School of Medicine, Aomori, Japan.
  • Shirakawa T; Department of Urology, Juntendo University, Graduate School of Medicine, Tokyo, Japan.
  • Fujii Y; Department of Urology, Tokyo Medical and Dental University, Tokyo, Japan.
  • Kumano H; Faculty of Human Sciences, Waseda University, Saitama, Japan.
  • Ueshiba H; Division of Diabetes, Metabolism and Endocrinology, Toho University Ohashi Medical Center, Tokyo, Japan.
  • Amano T; Department of Urology, Nagano Red Cross Hospital, Nagano, Japan.
  • Sasaki H; Department of Urology, Showa University Fujigaoka Hospital, Kanagawa, Japan.
  • Maeda S; Faculty of Sport Sciences, Waseda University, Saitama, Japan.
  • Mizokami A; Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Ishikawa, Japan.
  • Suzuki K; Department of Urology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan.
  • Horie S; Department of Urology, Juntendo University, Graduate School of Medicine, Tokyo, Japan.
Int J Urol ; 30(5): 422-430, 2023 05.
Article en En | MEDLINE | ID: mdl-36757880
ABSTRACT
Testosterone plays an important role in maintaining both physical and mental function. Age-related testosterone depletion contributes to the development of angina, arteriosclerosis, obesity, metabolic syndrome, dementia, frailty, and a range of other conditions. A condition involving age-related testosterone depletion and the associated clinical symptoms is defined as late-onset hypogonadism (LOH). LOH is treated by testosterone replacement therapy. Indications for testosterone replacement therapy are determined by evaluating symptoms and signs.
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Síndrome Metabólico / Hipogonadismo Tipo de estudio: Diagnostic_studies / Guideline Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Síndrome Metabólico / Hipogonadismo Tipo de estudio: Diagnostic_studies / Guideline Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article